XENE
Xenon Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
7.15 / 10
Outperform
Sentiment scores 7.15 (outperform) and fund‑flow 7.85 (good), with overall and block inflows positive, extra‑large buying strong, while small/medium/large investors net out. Analyst consensus is 100% bullish (40% Strong Buy, 60% Buy). Momentum is favorable despite mixed size‑segment flows.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
40%
Buy
60%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-10
InstitutionWells Fargo
Times predicted5
Historical Win Rate60.0%
Is money flowing into or out of XENE?
- XENE holds a Bullish analyst rating, with 60% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.15/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
